Pharmacy Management

Effective medication management requires active patient involvement and understanding.

Pharmacists enhance community health by offering test-and-treat services for COVID-19, influenza, strep, and RSV, improving access to care.

Sarah J. Billups, PharmD, highlights the disconnect between medication adherence metrics and actual patient outcomes, urging a reevaluation of adherence measures in health care.

Pharmacists explore AI's transformative potential, evaluating its applications and ensuring ethical integration to enhance patient care and pharmacy operations.

Economic factors are driving sterile injectable drug shortages, but collaborative strategies can enhance health care industry resiliency.

Tech-Check-Tech Improves Workflow and Allows Pharmacists to Focus on Clinical Responsibilities

Explore recent policy actions focused on PBM regulation, expanded pharmacy vaccine authority, and federal drug-pricing reforms.

Amir Masood, PharmD, is director of pharmacy operations at Safeway – Mid-Atlantic Division.

The Latest Kaiser Family Foundation Employer Health Benefits Survey Has Unsurprising but Consequential Findings

Clear communication, personalized counseling, and supportive environments help address barriers, empower patients, and enhance outcomes.

Each month, Timothy Ulbrich will share lessons on mindset, strategy, and habits to help pharmacists achieve lasting security and financial freedom.

Many factors lead to policy change and market viability, but none more than perceived need and desire to receive a service.

Explore the booming online pharmacy market for vitamins and supplements, and discover how pharmacists can guide patients in this digital landscape.

Pharmacists learn to recognize and combat burnout through self-awareness, open dialogue, and supportive workplace strategies for lasting well-being.

Individualized interventions, medication reconciliation, and postdischarge follow-up help reduce errors and elevate care continuity.

AI is redefining the workforce by enhancing care and efficiency.

Engagement and recognition of pharmacist expertise grows as state psychedelic bills expand.

Abdulwhab Shremo Msdi, PharmD, BCIDP, advances research in infectious diseases and microbiome-related conditions.

The rationale for vaccine-related policy changes is lacking.

Legislative efforts aim to improve oncology medication access, addressing transportation barriers and advocating for mail delivery from cancer clinics.

Employers are facing higher costs and employees higher premiums as 340B’s growth drives lost rebates and rising drug prices.

Expert emphasizes the need for stronger transparency and patient definitions in the 340B program.

An expert shares how 340B puts independent pharmacies at a competitive disadvantage.

The law has support from patients, health care providers, pharmacists, and the largest health insurance provider in the state.